Skip to main content

Inhibition of Histone Deacetylases

  • Protocol
Book cover Epigenetics Protocols

Part of the book series: Methods in Molecular Biology™ ((MIMB,volume 287))

  • 2627 Accesses

Abstract

Reversible histone acetylation, governed dynamically by histone acetyltransferases (HATs) and histone deacetylases (HDACs), plays a pivotal role in regulation of gene expression through remodeling chromatin structure. Manipulation of the equilibrium between acetylation and deacetylation of histones by specific HDAC inhibitors is thus a useful tool to study functional role(s) for histone hyper-/hypoacetylation in controlling gene transcription and many other cellular activities. By using the trans-activating effect of trichostatin A (TSA), a widely used HDAC inhibitor, on the telomerase reverse transcriptase (hTERT) gene as an example, we summarize various aspects of HDAC inhibitors and provide a general strategy for their in vitro application in studies of gene regulation.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Protocol
USD 49.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Bannister, A. J., and Miska, E. A. (2000) Regulation of gene expression by transcription factor acetylation. Cell Mol Life Sci. 57, 1184–1192.

    Article  PubMed  CAS  Google Scholar 

  2. Struhl, K. (1998) Histone acetylation and transcriptional regulatory mechanisms. Genes Dev. 12, 599–606.

    Article  PubMed  CAS  Google Scholar 

  3. Shankaranarayanan, P., Chaitidis, P., Kuhn, H., and Nigam, S. (2001) Acetylation by histone acetyltransferase CREB-binding protein/p300 of STAT6 is required for transcriptional activation of the 15-lipoxygenase-1 gene. J Biol Chem. 276, 42,753–42,760.

    Article  PubMed  CAS  Google Scholar 

  4. Yoshida, M., Horinouchi, S., and Beppu, T. (1995) Trichostatin A and trapoxin: novel chemical probes for the role of histone acetylation in chromatin structure and function. Bioessays 17, 423–430.

    Article  PubMed  CAS  Google Scholar 

  5. Nimmanapalli, R., Fuino, L., Stobaugh, C., Richon, V. M., and Bhalla, K. (2003) Co-treatment with the histone deacetylase inhibitor suberoylanilide hydroxamic acid (SAHA) enhances Gleevec-induced apoptosis of Bcr-Abl positive human acute leukemia cells. DOI 10.1182 Blood 101, 3236–3239.

    Article  PubMed  CAS  Google Scholar 

  6. Colletti, S. L., Myers, R. W., Darkin-Rattray, S. J., et al. (2001) Broad spectrum antiprotozoal agents that inhibit histone deacetylase: structure-activity relationships of apicidin. Bioorg. Med. Chem. Lett. 11, 107–117.

    Article  PubMed  CAS  Google Scholar 

  7. Lee, B. I., Park, S. H., Kim, J. W., et al. (2001) MS-275, a histone deacetylase inhibitor, selectively induces transforming growth factor beta type II receptor expression in human breast cancer cells. Cancer Res. 61, 931–934.

    PubMed  CAS  Google Scholar 

  8. Redner, R. L., Wang, J., and Liu, J. M. (1999) Chromatin remodeling and leukemia: new therapeutic paradigms. Blood 94, 417–428.

    PubMed  CAS  Google Scholar 

  9. Kamitani, H., Geller, M., and Eling, T. (1998) Expression of 15-lipoxygenase by human colorectal carcinoma Caco-2 cells during apoptosis and cell differentiation. J. Biol. Chem. 273, 21,569–21,577.

    Article  PubMed  CAS  Google Scholar 

  10. Bernhard, D., Ausserlechner, M. J., Tonko, M., Loffler, M., Hartmann, B. L., Csordas, A., and Kofler, R. (1999) Apoptosis induced by the histone deacetylase inhibitor sodium butyrate in human leukemic lymphoblasts. FASEB J. 13, 1991–2001.

    PubMed  CAS  Google Scholar 

  11. Taplick, J., Kurtev, V., Lagger, G., and Seiser, C. (1998) Histone H4 acetylation during interleukin-2 stimulation of mouse T cells. FEBS Lett. 436, 349–352.

    Article  PubMed  CAS  Google Scholar 

  12. Salminen, A., Tapiola, T., Korhonen, P., and Suuronen, T. (1998) Neuronal apoptosis induced by histone deacetylase inhibitors. Brain Res. Mol. Brain Res. 61, 203–206.

    Article  PubMed  CAS  Google Scholar 

  13. Han, J. W., Ahn, S. H., Park, S. H., et al. (2000) Apicidin, a histone deacetylase inhibitor, inhibits proliferation of tumor cells via induction of p21WAF1/Cip1 and gelsolin. Cancer Res. 60, 6068–6074.

    PubMed  CAS  Google Scholar 

  14. Saito, A., Yamashita, T., Mariko, Y., et al. (1999) A synthetic inhibitor of histone deacetylase, MS-27–275, with marked in vivo antitumor activity against human tumors. Proc. Natl. Acad. Sci. USA 96, 4592–4597.

    Article  PubMed  CAS  Google Scholar 

  15. Marks, P. A., Richon, V. M., and Rifkind, R. A. (2000) Histone deacetylase inhibitors: inducers of differentiation or apoptosis of transformed cells. J. Natl. Cancer Inst. 92, 1210–1216.

    Article  PubMed  CAS  Google Scholar 

  16. Zhou, Q., Melkoumian, Z. K., Lucktong, A., Moniwa, M., Davie, J. R., and Strobl, J. S. (2000) Rapid induction of histone hyperacetylation and cellular differentiation in human breast tumor cell lines following degradation of histone deacetylase-1. J. Biol. Chem. 275, 35,256–35,263.

    Article  PubMed  CAS  Google Scholar 

  17. Hou, M., Wang, X., Popov, N., et al. (2002) The histone deacetylase inhibitor trichostatin A derepresses the telomerase reverse transcriptase (hTERT) gene in human cells. Exp. Cell Res. 274, 25–34.

    Article  PubMed  CAS  Google Scholar 

  18. Cong, Y. S. and Bacchetti, S. (2000) Histone deacetylation is involved in the transcriptional repression of hTERT in normal human cells. J. Biol. Chem. 275, 35,665–35,668.

    Article  PubMed  CAS  Google Scholar 

  19. Taniura, S., Kamitani, H., Watanabe, T., and Eling, T. E. (2002) Transcriptional regulation of cyclooxygenase-1 by histone deacetylase inhibitors in normal human astrocyte cells. J. Biol. Chem. 277, 16,823–16,830.

    Article  PubMed  CAS  Google Scholar 

  20. Kamitani, H., Taniura, S., Ikawa, H., Watanabe, T., Kelavkar, U. P., and Eling, T. E. (2001) Expression of 15-lipoxygenase-1 is regulated by histone acetylation in human colorectal carcinoma. Carcinogenesis 22, 187–191.

    Article  PubMed  CAS  Google Scholar 

  21. Takakura, M., Kyo, S., Sowa, Y., et al. (2001) Telomerase activation by histone deacetylase inhibitor in normal cells. Nucleic Acids Res. 29, 3006–3011.

    Article  PubMed  CAS  Google Scholar 

  22. Sowa, Y., Orita, T., Minamikawa-Hiranabe, S., Mizuno, T., Nomura, H., and Sakai, T. (1999) Sp3, but not Sp1, mediates the transcriptional activation of the p21/WAF1/Cip1 gene promoter by histone deacetylase inhibitor. Cancer Res. 59, 4266–4270.

    PubMed  CAS  Google Scholar 

  23. Schwab, J. and Illges, H. (2001) Regulation of CD21 expression by DNA methylation and histone deacetylation. Int. Immunol. 13, 705–710.

    Article  PubMed  CAS  Google Scholar 

  24. Eickhoff, B., Germeroth, L., Stahl, C, et al. (2000) Trichostatin A-mediated regulation of gene expression and protein kinase activities: reprogramming tumor cells for ribotoxic stress-induced apoptosis. Biol. Chem. 381, 1127–1132.

    Article  PubMed  CAS  Google Scholar 

  25. Nakayama, T., Watanabe, M., Yamanaka, M., et al. (2001) The role of epigenetic modifications in retinoic acid receptor beta2 gene expression in human prostate cancers. Lab Invest. 81, 1049–1057.

    PubMed  CAS  Google Scholar 

  26. Rombouts, K., Niki, T., Greenwel, P., et al. (2002) Trichostatin A, a histone deacetylase inhibitor, suppresses collagen synthesis and prevents TGF-beta(1)-induced fibrogenesis in skin fibroblasts. Exp. Cell Res. 278, 184–197.

    Article  PubMed  CAS  Google Scholar 

  27. Qiu, P. and Li, L. (2002) Histone acetylation and recruitment of serum responsive factor and CREB-binding protein onto SM22 promoter during SM22 gene expression. Circ. Res. 90, 858–865.

    Article  PubMed  CAS  Google Scholar 

  28. Gregory, R. I., O’Neill, L. P., Randall, T. E., et al. (2002) Inhibition of histone deacetylases alters allelic chromatin conformation at the imprinted U2af1-rs1 locus in mouse embryonic stem cells. J. Biol. Chem. 277, 11,728–11,734.

    Article  PubMed  CAS  Google Scholar 

  29. Xiao, H., Hasegawa, T., and Isobe, K. (1999) Both Sp1 and Sp3 are responsible for p21waf1 promoter activity induced by histone deacetylase inhibitor in NIH3T3 cells. J. Cell Biochem. 73, 291–302.

    Article  PubMed  CAS  Google Scholar 

  30. Wang, X. Q., Alfaro, M. L., Evans, G. F., and Zuckerman, S. H. (2002) Histone deacetylase inhibition results in decreased macrophage CD9 expression. Biochem. Biophys. Res. Commun. 294, 660–666.

    Article  PubMed  CAS  Google Scholar 

  31. Xu, D., Popov, N., Hou, M., et al. (2001) Switch from Myc/Max to Mad1/Max binding and decrease in histone acetylation at the telomerase reverse transcriptase promoter during differentiation of HL60 cells. Proc. Natl. Acad. Sci. USA 98, 3826–3831.

    Article  PubMed  CAS  Google Scholar 

  32. Van Lint, C., Emiliani, S., and Verdin, E. (1996) The expression of a small fraction of cellular genes is changed in response to histone hyperacetylation. Gene. Expr. 5, 245–253.

    PubMed  Google Scholar 

  33. Gray, S. G. and Ekstrom, T. J. (1998) Effects of cell density and trichostatin A on the expression of HDAC1 and p57Kip2 in Hep 3B cells. Biochem. Biophys. Res. Commun. 245, 423–427.

    Article  PubMed  CAS  Google Scholar 

  34. Thiagalingam, S., Cheng, K. H., Lee, H. J., Mineva, N., Thiagalingam, A., and Ponte, J. F. (2003) Histone deacetylases: unique players in shaping the epigenetic histone code. Ann. NY Acad. Sci. 983, 84–100.

    Article  PubMed  CAS  Google Scholar 

  35. Suenaga, M., Soda, H., Oka, M., et al. (2002) Histone deacetylase inhibitors suppress telomerase reverse transcriptase mRNA expression in prostate cancer cells. Int. J. Cancer 97, 621–625.

    Article  PubMed  CAS  Google Scholar 

  36. Ito, K., Barnes, P. J., and Adcock, I. M. (2000) Glucocorticoid receptor recruitment of histone deacetylase 2 inhibits interleukin-1beta-induced histone H4 acetylation on lysines 8 and 12. Mol. Cell. Biol. 20, 6891–6903.

    Article  PubMed  CAS  Google Scholar 

  37. Zhang, W., Bone, J. R., Edmondson, D. G., Turner, B. M., and Roth, S. Y. (1998) Essential and redundant functions of histone acetylation revealed by mutation of target lysines and loss of the Gcn5p acetyltransferase. EMBO J. 17, 3155–3167.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2004 Humana Press Inc., Totowa, NJ

About this protocol

Cite this protocol

Liu, C., Xu, D. (2004). Inhibition of Histone Deacetylases. In: Tollefsbol, T.O. (eds) Epigenetics Protocols. Methods in Molecular Biology™, vol 287. Humana Press. https://doi.org/10.1385/1-59259-828-5:087

Download citation

  • DOI: https://doi.org/10.1385/1-59259-828-5:087

  • Publisher Name: Humana Press

  • Print ISBN: 978-1-58829-336-7

  • Online ISBN: 978-1-59259-828-1

  • eBook Packages: Springer Protocols

Publish with us

Policies and ethics